Rallybio Employee Directory
Biotechnology ResearchConnecticut, United States11-50 Employees
Rallybio is a clinical-stage biotechnology company focused on developing therapies for severe and rare diseases. It is in the biotechnology research industry and is headquartered in New Haven, Connecticut, at 234 Church Street, Suite 1020, New Haven, CT 06510, United States. The company maintains a pipeline that includes RLYB116, a differentiated C5 inhibitor targeting diseases of complement dysregulation, with an initial focus on immune platelet transfusion refractoriness and refractory antiphospholipid syndrome. A second program, RLYB332, is a preclinical long-acting matriptase-2 antibody aimed at treating iron overload. Rallybio trades on the NASDAQ under the ticker RLYB.